Lies Lahousse

Lies Lahousse is an Associate Professor in the Department of Epidemiology at Erasmus MC, a leading medical university center in the Netherlands. Her research is centered on population-level health outcomes, particularly in respiratory and cardiovascular diseases, utilizing large-scale cohort studies and pharmacoepidemiological methods.

Her research interests span chronic obstructive pulmonary disease (COPD), atrial fibrillation, anticoagulant therapy, and drug-drug interactions. She investigates how medication adherence, pharmacodynamic interactions, and comorbidities affect clinical outcomes in real-world populations. Her work frequently employs nationwide cohort designs, enabling robust statistical analysis of health risks and treatment effectiveness.

The recent trends in her publications indicate a strong focus on respiratory epidemiology and cardiovascular pharmacology, particularly examining the interplay between COPD and sleep disorders, as well as the safety and efficacy of non-vitamin K antagonist oral anticoagulants (NOACs). Her studies often address sex-specific risks, staging systems for airflow limitation, and minimal adherence thresholds necessary for therapeutic benefit.

Lies Lahousse actively supervises research, including doctoral theses, and collaborates extensively with national and international researchers in respiratory and cardiovascular medicine. Her work contributes significantly to evidence-based guidelines in pulmonology and cardiology.